Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Economy News How Soaring Demand For Ozempic And Wegovy Is Altering Denmark’s Economy is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Ozempic Maker Novo Nordisk Is a Problem as Denmark’s Economy Hits a Wall
The economy ministry blamed the slowdown on U.S. tariffs, but faltering demand for Ozempic and Wegovy could be another factor. Read More
Denmark flaunts 1.3% economic growth — but experts warn Ozempic profits mask deeper troubles
Denmark’s economy staged a strong recovery in the second quarter of the year, bouncing back from a difficult start. New figures from Statistics Denmark show that the country’s gross domestic product ... Read More
How Novo Nordisk Hurt Denmark’s Economy
Denmark cut its annual growth outlook on Friday—and one of the Scandinavian country’s best-known companies may be a part of the problem. Read More
Novo Nordisk, maker of Wegovy and Ozempic, to cut 9,000 jobs
The Danish pharmaceutical company said it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company's focus on growth opportunities in obesity and diabetes medications. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus